Business Context and Reporting Period
Company: Acadia Healthcare Company, Inc.
Filing Type: Form 8-K (Current Report)
Date: September 29, 2025
Context: The filing discloses preliminary 2026 guidance and select interim operating results for the third quarter of 2025 in conjunction with a fireside chat at the Jefferies 2025 Healthcare Services Conference.
Key Financial Metrics and Operational Data
- 2026 Capital Expenditures: Expected to decline by at least $300 million relative to the 2025 guidance range of $600 million to $650 million.
- 2026 Bed Growth: Expected addition of 500 to 700 beds, inclusive of beds currently under construction in 2025.
- Q3 2025 Interim Result: Same facility patient days growth to date is approximately 1.3%.
- Revenue, Profit, Cash Flow, Debt, Liquidity: The filing text does not provide specific values for revenue, net income, operating cash flow, debt levels, or liquidity ratios.
Material Changes Versus Prior Period
- Capital Expenditure Reduction: A significant downward revision in capital spending for 2026 compared to the previously issued 2025 guidance.
- Operational Growth: Continued expansion in bed capacity and positive same-facility patient day growth in Q3 2025.
Guidance, Outlook, Risks, and Contingencies
Management Commentary and Outlook
Management is providing forward-looking statements regarding strategy and anticipated operating results. The company expects to reduce capital intensity in 2026 while continuing facility expansion.
Material Risks and Contingencies
- Regulatory and Legislative Impact: Significant changes to Medicaid financing mechanisms introduced by the "One Big Beautiful Bill Act" (OBBBA) enacted on July 4, 2025, including potential payment reductions and work/community engagement requirements for the Medicaid expansion population.
- Operational Risks: Difficulties in integrating acquired facilities, realizing synergies, and adding beds efficiently.
- Legal and Compliance: Risks related to patient incidents, governmental investigations, litigation, and adverse regulatory actions.
- Financial Risks: Potential inability to generate sufficient cash from operations to service debt and meet working capital requirements.
- External Factors: Cybersecurity incidents, labor and supply chain cost increases, and general economic disruptions.
Investor Verification Checklist
- Verify the specific impact of the "One Big Beautiful Bill Act" (OBBBA) on Medicaid reimbursement rates and patient volume.
- Confirm the revised 2026 capital expenditure budget and the rationale for the $300 million+ reduction.
- Review the full Q3 2025 financial results (revenue, EBITDA, net income) in the upcoming Form 10-Q to contextualize the 1.3% same-facility patient day growth.
- Assess the company's debt service coverage ratio given the risks cited regarding cash flow generation.
- Monitor progress on the 500-700 bed expansion target for 2026.